PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsBisacodyl
Bisacodyl
Halflytely (bisacodyl) is a small molecule pharmaceutical. Bisacodyl was first approved as Halflytely on 2010-07-16. It is used to treat constipation in the USA.
Download report
Favorite
Top OTC Drugs
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Bisacodyl
+
Polyethylene glycol 3350
+
Potassium chloride
+
Sodium bicarbonate
+
Sodium chloride
Tradename
Company
Number
Date
Products
HALFLYTELYBraintree LaboratoriesN-021551 DISCN2010-07-16
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
avedana gentle laxativeC2002632024-11-26
bisac-10 bisacodyl stimulant laxativeOTC monograph not final2023-04-28
bisacodyOTC monograph not final2022-11-01
bisacodylC2002632025-02-10
bisacodyl 5mgC2002632019-03-26
bisacodyl laxativeC2002632024-11-07
c-lax laxativeC2002632025-01-22
conlaxC2002632024-12-21
cvs fast relief laxativeOTC monograph not final2014-10-03
cvs gentle laxativeC2002632024-12-25
Show 54 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
constipation—D003248K59.0
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A06: Drugs for constipation
— A06A: Drugs for constipation
— A06AB: Contact laxatives
— A06AB02: Bisacodyl
— A06AB52: Bisacodyl, combinations
— A06AG: Enema for constipation
— A06AG02: Bisacodyl
HCPCS
No data
Clinical
Clinical Trials
107 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ColonoscopyD003113————13—4
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBisacodyl
INNbisacodyl
Description
Bisacodyl is a diarylmethane.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1
Identifiers
PDB—
CAS-ID603-50-9
RxCUI—
ChEMBL IDCHEMBL942
ChEBI ID—
PubChem CID2391
DrugBankDB09020
UNII ID10X0709Y6I (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Bisacodyl
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 2,639 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
5,686 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use